Clinical Trials Browser

Phase 2 × Sarcoma, Kaposi × Didanosine × Clear all

NCT00001114 2021-11-01

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Phase 2 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections